Business Standard

Street Signs: High cost of trading, Akums Drugs GMP at 25%, and more

Shares of Akums Drugs and Pharmaceuticals commanded a grey market premium of 25 per cent ahead of its initial public offering (IPO)

Market, Stock Market, BSE, NSE, NIfty
Premium

(Photo: Reuters)

Samie Modak Mumbai

Listen to This Article

Eight-week winning streak: Nifty’s endurance race continues

Thanks to strong gains on Friday, the benchmark National Stock Exchange Nifty 50 Index managed to cap its eighth straight weekly advance — its longest weekly gaining streak since January 2018. During these eight weeks starting May 27, the blue-chip index has added 2,304 points, or 10.2 per cent. If the Nifty gains for one more week, it will mark the longest streak since March 2010. Although the market is in an extremely ‘overbought’ zone, making the possibility slim, it is not impossible. Experts suggest that the strong buy-the-dip pattern indicates that any

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in